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Abstract In this case report, we describe a patient with
longstanding rheumatoid arthritis who developed tracheo-
bronchomalacia with fatal outcome. Despite negative
antemortem biopsies of abdominal fat and tongue, amyloid
was found postmortem in the trachea and appeared to be
associated with tracheobronchomalacia.
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Introduction
Amyloidosis in longstanding chronically active rheumatoid
arthritis (RA) is a well-known complication of this disease
[1]. We present a RA patient with amyloidosis, albeit with
a unique presenting symptom and unexpected organ
involvement.
Case report
The patient was a 69-year-old female with seropositive
erosive RA, who had not been treated with disease-
modifying antirheumatic drugs since 1984. In March
2005, she presented to another hospital because of
progressive dyspnea of several hours, due to a broncho-
pneumonia. After 2 days, she developed a stridor. Otolaryn-
gological examination results showed diffuse swelling of
the tongue, pharynx and neck, and an extensive tracheo-
bronchomalacia. Treatment consisted of intubation, anti-
biotics, diuretic therapy, and corticosteroids. She was
admitted to our Intensive Care Unit because of progressive
swelling and respiratory insufficiency due to tracheobron-
chomalacia. Physical examination results revealed exten-
sive swelling and a remarkable protrusion of the tongue.
Typical rheumatoid joint deformities and rheumatoid
nodules were present but no active arthritis. Laboratory
investigations revealed a normocytic anemia and a renal
insufficiency. The measured creatinine clearance was
12 ml/min, with a proteinuria of 0.35 g/24 h. Computed
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tion for the tracheobronchomalacia. Clinical suspicion of
amyloidosis was not confirmed by biopsies of abdominal
fat tissue and of the tongue. Ultimately, the patient
succumbed to multiple organ failure. Autopsy revealed
AA amyloid in the trachea (Fig. 1), spleen, liver, and
perivascularly in the kidneys.
Discussion
Amyloidosis of the trachea is a rare but known disorder,
even rarer in patients with systemic diseases (such as
Sjogren syndrome) but never associated with tracheobron-
chomalacia [2–4]. We report the first case of an RA patient
with tracheobronchomalacia due to AA amyloidosis of the
trachea. The diagnosis was only confirmed at postmortem,
although several biopsies had been done in life to confirm
the clinical suspicion. We refrained from rectal and kidney
biopsies because of the relatively high risk of complications
associated with these procedures; the absence of diarrhea
and the low level of proteinuria suggested a relatively low
pretest probability. Therefore, the finding of renal amyloid
was surprising. Recently, Uda et al. [5] described a
prospective cohort study of patients with RA without
clinical signs of kidney disease and amyloidosis of the
kidney. At follow-up, the group of patients with amyloid
deposition confined to the perivascular region continued to
have little proteinuria and a good renal prognosis, com-
pared to those with amyloid deposition in the glomeruli
who developed rapidly deteriorating renal function. This
patient, however, does show that the disease course in RA
patients with perivascular amyloid deposition in the kidney
is not benign and may be associated with fatal complica-
tions elsewhere.
In conclusion, tracheobronchomalacia can be due to
amyloid deposition in patients with RA. Amyloidosis
should be considered in RA patients with a small amount
of proteinuria, and a renal biopsy should be performed,
especially as accumulating evidence shows that patients
with amyloidosis have a better prognosis when the ongoing
inflammation is effectively suppressed [1].
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Fig. 1 Amyloidosis of the trachea in Congo red
808 Clin Rheumatol (2008) 27:807–808